In metabolic disorders (including obesity and type 2 diabetes), adipose tissue frequently exhibits elevated basal lipolysis, which leads to chronically high FFA levels or ectopic lipid deposition, and further impairing insulin signaling both in the liver and skeletal muscle (219). The gene discussed is INS; the disease is metabolic disease.